CLINICAL_TRIALS
withdrawal
· 2024-12-13
Clinical Trial Update: Skin Immunity Sample Collection Involving Blisters and Biopsies [EARLY_Phase 1]
Summary
A Phase 1 clinical trial involving skin immunity sample collection for patients with Hyper-Immunoglobulin E Syndrome and Chronic Granulomatous Disease has been …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Hyper-Immunoglobulin E. Syndrome (HEIS), Chronic Granulomatous Disease (CGD) | EARLY_Phase 1 | Status: WITHDRAWN